Curia Announces Strategic Refinancing to Support Continued Growth
ALBANY, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia),…
NewGen Issues Clarification on Press Release Titled NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director dated February 20, 2025
February 20, 2025 16:30 ET | Source: NewGenIvf Limited BANGKOK, Feb. 21,…
Three-Year Results for EYLEA HD (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals
At three years of EYLEA HD treatment, the vast majority of patients…
AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
February 07, 2025 16:05 ET | Source: AEON Biopharma IRVINE, Calif., Feb.…
Nearly three-in-five CEOs optimistic about global economic outlook as they plan headcount increases and continued AI rollout: PwC 2025 Global CEO Survey
Almost 60% of CEOs expect global growth to increase over the next…
Nearly three-in-five CEOs optimistic about global economic outlook as they plan headcount increases and continued AI rollout: PwC 2025 Global CEO Survey
Almost 60% of CEOs expect global growth to increase over the next…
Nearly three-in-five CEOs optimistic about global economic outlook as they plan headcount increases and continued AI rollout: PwC 2025 Global CEO Survey
Almost 60% of CEOs expect global growth to increase over the next…
Faraday Future Secures $30 Million Financing to Strengthen the Companys Core Business and Continued Ramp-Up of the Faraday X (FX) Strategy
LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (“FF”, “Faraday Future”,…
AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
OCALA, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE…
IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
Based on more than six months of additional monitoring, data show continued…